Home › Therapeutic areas › Renal › Immunoglobulin A Nephropathy

Immunoglobulin A Nephropathy (8 companies)

Companies with an active program in Immunoglobulin A Nephropathy.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AKBA Akebia Therapeutics HematologyOphthalmology+2 Rare 1 Approved $111M 10
CLYM Climb Bio HematologyImmunology+1 Rare 1 Phase 2 $574M 8
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 1 Approved $4.49B 29
JBIO Jade Biosciences ImmunologyRenal Rare 1 Phase 2 $1.07B 4
NVCT Nuvectis Pharma HematologyOncology+1 Rare 1 Phase 3 $660M 9
PCSA Processa Pharmaceuticals GI/HepatologyImmunology+2 Rare 1 Phase 2 $4.8M 7
TVTX Travere Therapeutics MetabolicRenal Rare 1 Approved $4.91B 7
VERA Vera Therapeutics Infectious DiseaseRenal Rare 1 Approved $1.89B 6